English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, February 1, 2023
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China
Monday, January 30, 2023
欧康维视生物分别任命阮添士先生及王冲先生为首席财务官及投资者关系负责人
歐康維視生物分別任命阮添士先生及王沖先生為首席財務官及投資者關係負責人
Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively
Saturday, March 20, 2021
欧康维视 (1477.HK) 公布2020年全年业绩
歐康維視 (1477.HK) 公佈2020年全年業績
Ocumension Therapeutics (1477.HK) Announces 2020 Annual Results
Tuesday, November 17, 2020
欧康维视生物荣获格隆汇2020大中华区最佳上市公司 -「最受关注IPO」大奖
歐康維視生物榮獲格隆匯2020大中華區最佳上市公司 -「最受關注IPO」大獎
Thursday, August 27, 2020
欧康维视中报巨亏起底 这家眼科新贵手握大把现金,其实不差钱?

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575